Talphera, Inc. (TLPH)
0.73
-0.01
(-1.22%)
USD |
NASDAQ |
Nov 20, 10:35
Talphera Cash from Operations (Quarterly) : -3.034M for Sept. 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -3.034M |
| June 30, 2026 | -3.924M |
| March 31, 2026 | -3.40M |
| December 31, 2025 | -2.436M |
| September 30, 2025 | -2.51M |
| June 30, 2025 | -2.948M |
| March 31, 2025 | -3.47M |
| December 31, 2024 | -2.254M |
| September 30, 2024 | -2.936M |
| June 30, 2024 | -4.61M |
| March 31, 2024 | -2.883M |
| December 31, 2023 | -3.949M |
| September 30, 2023 | -2.96M |
| June 30, 2023 | -5.333M |
| March 31, 2023 | -5.25M |
| December 31, 2022 | -5.413M |
| September 30, 2022 | -5.238M |
| June 30, 2022 | -8.746M |
| March 31, 2022 | -8.934M |
| December 31, 2021 | -8.004M |
| September 30, 2021 | -3.943M |
| June 30, 2021 | -8.347M |
| March 31, 2021 | -9.708M |
| December 31, 2020 | -6.327M |
| September 30, 2020 | -8.124M |
| Date | Value |
|---|---|
| June 30, 2020 | -9.69M |
| March 31, 2020 | -14.36M |
| December 31, 2019 | -14.16M |
| September 30, 2019 | -11.47M |
| June 30, 2019 | -12.32M |
| March 31, 2019 | -13.24M |
| December 31, 2018 | -8.99M |
| September 30, 2018 | -6.301M |
| June 30, 2018 | -6.41M |
| March 31, 2018 | -7.374M |
| December 31, 2017 | -6.676M |
| September 30, 2017 | -6.784M |
| June 30, 2017 | -8.77M |
| March 31, 2017 | -7.535M |
| December 31, 2016 | -10.32M |
| September 30, 2016 | -4.613M |
| June 30, 2016 | -8.238M |
| March 31, 2016 | -6.229M |
| December 31, 2015 | 6.995M |
| September 30, 2015 | -5.51M |
| June 30, 2015 | -10.69M |
| March 31, 2015 | -10.75M |
| December 31, 2014 | -8.921M |
| September 30, 2014 | -5.592M |
| June 30, 2014 | -9.811M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Relmada Therapeutics, Inc. | -12.59M |
| Journey Medical Corp. | -3.437M |
| ANI Pharmaceuticals, Inc. | 83.79M |
| Corcept Therapeutics, Inc. | 142.89M |
| Veru, Inc. | -5.467M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 12.92M |
| Cash from Financing (Quarterly) | 0.032M |
| Free Cash Flow | -12.79M |
| Free Cash Flow Per Share (Quarterly) | -0.0402 |
| Free Cash Flow to Equity (Quarterly) | -3.034M |
| Free Cash Flow to Firm (Quarterly) | -3.034M |
| Free Cash Flow Yield | -33.74% |